Bank Of America Corp Denali Therapeutics Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 742,048 shares of DNLI stock, worth $23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

742,048

Previous 851,976 12.9%

Holding current value

$23 Million

Previous $17.5 Million 1.44%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.96 - $23.22 $1.64 Million - $2.55 Million	-109,928 Reduced 12.9%	742,048 $17.2 Million
Q1 2024 May 15, 2024	BUY	$15.83 - $23.35 $6.23 Million - $9.18 Million	393,338 Added 85.76%	851,976 $17.5 Million
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $3.05 Million - $4.37 Million	188,393 Added 69.71%	458,638 $9.84 Million
Q2 2023 Aug 14, 2023	SELL	$23.37 - $32.96 $3.5 Million - $4.93 Million	-149,591 Reduced 35.63%	270,245 $7.97 Million
Q1 2023 May 12, 2023	BUY	$21.91 - $32.67 $1.86 Million - $2.78 Million	85,064 Added 25.41%	419,836 $9.67 Million
Q4 2022 Feb 10, 2023	BUY	$26.28 - $33.92 $3.01 Million - $3.89 Million	114,555 Added 52.02%	334,772 $9.31 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $2.63 Million - $3.9 Million	101,150 Added 84.95%	220,217 $6.76 Million
Q2 2022 Aug 12, 2022	SELL	$20.88 - $35.19 $2.55 Million - $4.3 Million	-122,168 Reduced 50.64%	119,067 $3.5 Million
Q1 2022 May 16, 2022	BUY	$29.0 - $47.27 $3.26 Million - $5.31 Million	112,287 Added 87.08%	241,235 $7.76 Million
Q4 2021 Feb 08, 2022	BUY	$42.59 - $55.02 $2.18 Million - $2.81 Million	51,102 Added 65.64%	128,948 $5.75 Million
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $683,277 - $1.1 Million	14,094 Added 22.11%	77,846 $3.93 Million
Q2 2021 Sep 13, 2021	BUY	$50.3 - $78.44 $3.21 Million - $5 Million	63,752 New	63,752 $5 Million

Others Institutions Holding DNLI

# of Institutions

214

Shares Held

121M

Call Options Held

127K

Put Options Held

38.3K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $4.17B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Denali Therapeutics Inc. Transaction History